Trial intelligence / Profile preview

Dexmedetomidine on Intraocular Pressure in Prone Spine Surgery

NCT04628663Recruiting

Sponsor
Attikon University Hospital
Start
Mar 2021
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Ocular hypertension comparing Dexmedetomidine Group with Placebo Group (2 arms). Primary endpoint: Intraocular pressure. Started Mar 2021; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

Ocular hypertension

Beyond the preview

Go deeper on NCT04628663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04628663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call